$2.64
0.11%
Downside
Day's Volatility :6.08%
Upside
5.97%
14.02%
Downside
52 Weeks Volatility :72.94%
Upside
68.53%
Period | Medirom Healthcare Technologies Inc | Index (Russel 2000) |
---|---|---|
3 Months | -4.03% | 0.0% |
6 Months | -51.5% | 0.0% |
1 Year | -45.52% | 0.0% |
3 Years | -65.75% | -26.7% |
Market Capitalization | 13.0M |
Book Value | $43.19 |
Earnings Per Share (EPS) | 0.15 |
PE Ratio | 17.59 |
Profit Margin | 1.69% |
Operating Margin TTM | -2.27% |
Return On Assets TTM | -3.6% |
Return On Equity TTM | 146.95% |
Revenue TTM | 6.8B |
Revenue Per Share TTM | 1398.45 |
Quarterly Revenue Growth YOY | -5.800000000000001% |
Gross Profit TTM | 1.4B |
EBITDA | -139.0M |
Diluted Eps TTM | 0.15 |
Quarterly Earnings Growth YOY | 0.58 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
FY18 | Y/Y Change | |
---|---|---|
Revenue | 30.6M | - |
Net Income | 590.5K | - |
Net Profit Margin | 1.93% | - |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 35.8M | ↑ 13.84% |
Net Income | 158.8K | ↓ 73.86% |
Net Profit Margin | 0.44% | ↓ 1.49% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 32.2M | ↓ 14.5% |
Net Income | -5.2M | ↓ 3210.3% |
Net Profit Margin | -16.14% | ↓ 16.58% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 47.5M | ↑ 61.89% |
Net Income | -8.7M | ↑ 83.75% |
Net Profit Margin | -18.31% | ↓ 2.17% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 51.5M | ↑ 28.54% |
Net Income | 1.1M | ↓ 115.04% |
Net Profit Margin | 2.14% | ↑ 20.45% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 47.5M | ↓ 1.81% |
Net Income | 799.8K | ↓ 22.77% |
Net Profit Margin | 1.68% | ↓ 0.46% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Revenue | 25.6M | - |
Net Income | -1.5M | - |
Net Profit Margin | -5.77% | - |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 190.7K | ↑ 6.46% |
Net Income | 16.6K | ↓ 260.22% |
Net Profit Margin | 8.68% | ↑ 14.45% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.6B | ↑ 5856.18% |
Net Income | -177.5M | ↓ 7612.13% |
Net Profit Margin | -10.95% | ↓ 19.63% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.6B | ↑ 0.0% |
Net Income | -177.5M | ↑ 0.0% |
Net Profit Margin | -10.95% | ↑ 0.0% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.8B | ↑ 10.56% |
Net Income | 235.2M | ↓ 232.5% |
Net Profit Margin | 13.12% | ↑ 24.07% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 40.3M | - |
Total Liabilities | 41.3M | - |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 43.6M | ↑ 5.21% |
Total Liabilities | 38.1M | ↓ 10.39% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 55.1M | ↑ 20.09% |
Total Liabilities | 50.3M | ↑ 25.61% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 50.5M | ↑ 0.69% |
Total Liabilities | 52.4M | ↑ 14.15% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 50.0M | ↑ 17.28% |
Total Liabilities | 50.4M | ↑ 14.18% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 47.6M | ↑ 1.51% |
Total Liabilities | 46.1M | ↓ 2.55% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 44.9M | ↓ 10.21% |
Total Liabilities | 47.9M | ↓ 4.9% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 45.3M | ↑ 0.0% |
Total Liabilities | 48.4M | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 42.8M | ↑ 0.0% |
Total Liabilities | 45.8M | ↑ 0.0% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 6.8B | ↑ 13.05% |
Total Liabilities | 6.6B | ↑ 2.47% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 47.6M | ↑ 0.0% |
Total Liabilities | 46.1M | ↑ 0.0% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 6.8B | ↑ 0.0% |
Total Liabilities | 6.6B | ↑ 0.0% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.3M | - |
Investing Cash Flow | -707.0K | - |
Financing Cash Flow | -663.2K | - |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 72.1K | ↓ 94.45% |
Investing Cash Flow | -347.4K | ↓ 52.22% |
Financing Cash Flow | 3.0M | ↓ 545.78% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -3.5M | ↓ 4755.91% |
Investing Cash Flow | -1.3M | ↑ 268.03% |
Financing Cash Flow | 13.8M | ↑ 331.37% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -4.9M | ↑ 52.07% |
Investing Cash Flow | -737.5K | ↓ 39.87% |
Financing Cash Flow | -3.8M | ↓ 129.88% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -143.2M | ↑ 37.05% |
Investing Cash Flow | 112.6M | ↓ 30.96% |
Financing Cash Flow | -104.4M | ↑ 105.34% |
Q2 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -2.3M | ↓ 98.37% |
Investing Cash Flow | 112.6M | ↑ 0.0% |
Financing Cash Flow | -494.0K | ↓ 99.53% |
Sell
Neutral
Buy
Medirom Healthcare Technologies Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Medirom Healthcare Technologies Inc | 0.65% | -51.5% | -45.52% | -65.75% | -82.55% |
Service Corporation International | 12.31% | 21.6% | 40.35% | 26.33% | 95.9% |
Frontdoor Inc | 10.65% | 53.57% | 59.1% | 48.65% | 30.01% |
Bright Horizons Family Solutions Inc | -16.87% | -3.15% | 27.15% | -18.55% | -19.65% |
H&r Block, Inc. | -2.13% | 11.92% | 29.75% | 141.79% | 139.94% |
Rollins Inc. | 2.25% | 9.31% | 29.91% | 42.95% | 105.27% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Medirom Healthcare Technologies Inc | 17.59 | 17.59 | NA | 0.0 | 1.47 | -0.04 | NA | 43.19 |
Service Corporation International | 25.12 | 25.12 | 1.79 | 3.52 | 0.31 | 0.03 | 0.01 | 11.22 |
Frontdoor Inc | 19.12 | 19.12 | NA | 3.19 | 1.08 | 0.19 | NA | 3.44 |
Bright Horizons Family Solutions Inc | 55.79 | 55.79 | 1.76 | 3.4 | 0.09 | 0.04 | NA | 24.07 |
H&r Block, Inc. | 14.77 | 14.77 | 0.26 | 4.3 | 0.98 | 0.19 | 0.03 | -2.69 |
Rollins Inc. | 52.88 | 52.88 | 3.5 | 0.99 | 0.39 | 0.15 | 0.01 | 2.72 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Medirom Healthcare Technologies Inc | NA | $13.0M | -82.55% | 17.59 | 1.69% |
Service Corporation International | Buy | $12.5B | 95.9% | 25.12 | 12.19% |
Frontdoor Inc | Buy | $4.4B | 30.01% | 19.12 | 12.81% |
Bright Horizons Family Solutions Inc | Buy | $6.5B | -19.65% | 55.79 | 4.44% |
H&r Block, Inc. | Buy | $8.1B | 139.94% | 14.77 | 16.19% |
Rollins Inc. | Buy | $24.8B | 105.27% | 52.88 | 14.18% |
Insights on Medirom Healthcare Technologies Inc
Revenue is up for the last 6 quarters, -2.63B → 1.79B (in $), with an average increase of 2101.7% per quarter
Netprofit is up for the last 2 quarters, -177.53M → 235.23M (in $), with an average increase of 175.5% per quarter
In the last 1 year, Frontdoor Inc has given 59.1% return, outperforming this stock by 104.6%
In the last 3 years, H&r Block, Inc. has given 51.7% return, outperforming this stock by 116.1%
Organization | Medirom Healthcare Technologies Inc |
Employees | 390 |
CEO | Mr. Kouji Eguchi |
Industry | Miscellaneous |
Cactus Acquisition Corp 1 Ltd
$2.64
-0.05%
Rigel Resource Acquisition Corp
$2.64
-0.05%
Fortune Rise Acquisition Corp
$2.64
-0.05%
Onyx Acquisition Co. I
$2.64
-0.05%
Lifeway Foods Inc
$2.64
-0.05%
Tectonic Therapeutic Inc
$2.64
-0.05%
Tuttle Capital Daily 2x Inverse Regional Banks Etf
$2.64
-0.05%
Jpmorgan Activebuilders Emer
$2.64
-0.05%
Rf Industries Ltd
$2.64
-0.05%